BTIG Starts Zealand Pharma A/S (ZEAL) at Buy, 'Leader in Obesity and Commercially Derisked Rare Diseases'
Tweet Send to a Friend
BTIG analyst Julian Harrison initiates coverage on Zealand Pharma A/S (NASDAQ: ZEAL) with a Buy rating.The analyst comments "ZEAL has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
